المؤلفون: Xue HY; The First Clinical Medical College of Shanxi Medical University, 56 Xinjian South Road, Yingze District, Taiyuan, Shanxi, China., Zhou L; Department of Nephropathy, Bao Ji High-Tech Hospital, Bao Ji, Shaanxi, People's Republic of China., Yuan QZ; Department of Bone and Soft Tissue Oncology, Cancer Hospital of the Chinese Academy of Medical Sciences, Shanxi Hospital, Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi, People's Republic of China., Zhang Y; Department of Hematology, The First Hospital of Shanxi Medical University, 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, People's Republic of China., Hao YQ; Department of Rheumatology and Immunology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China., Chen SW; Department of Hematology, The First Hospital of Shanxi Medical University, 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, People's Republic of China., Wang HK; Department of Pathology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China., Wei F; Department of Hematology, The First Hospital of Shanxi Medical University, 85 Jiefang South Road, Yingze District, Taiyuan, Shanxi, People's Republic of China. 2649929367@qq.com.

المصدر: Diagnostic pathology [Diagn Pathol] 2024 Jun 07; Vol. 19 (1), pp. 74. Date of Electronic Publication: 2024 Jun 07.

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101251558 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-1596 (Electronic) Linking ISSN: 17461596 NLM ISO Abbreviation: Diagn Pathol Subsets: MEDLINE

مواضيع طبية MeSH: POEMS Syndrome*/diagnosis , POEMS Syndrome*/pathology, Humans ; Male ; Middle Aged ; Lenalidomide/therapeutic use ; Thalidomide/therapeutic use ; Thalidomide/analogs & derivatives ; Vascular Endothelial Growth Factor A ; Dexamethasone/therapeutic use ; Treatment Outcome ; Myeloma Proteins/analysis

المؤلفون: Langerhorst P; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Baerenfaenger M; Department of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.; Division of BioAnalytical Chemistry, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Kulkarni P; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Nadal S; CY Cergy Paris Université, CNRS, BioCIS, Cergy-Pontoise, France., Wijnands C; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Post MA; Department of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands., Noori S; Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands., vanDuijn MM; Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands., Joosten I; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Dejoie T; Biochemistry Laboratory, Centre Hospitalier Universitaire (CHU), Nantes, France., van Gool AJ; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Gloerich J; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Lefeber DJ; Department of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands., Wessels HJCT; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Jacobs JFM; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

المصدر: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2024 Feb 09; Vol. 62 (8), pp. 1626-1635. Date of Electronic Publication: 2024 Feb 09 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Walter De Gruyter Country of Publication: Germany NLM ID: 9806306 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1437-4331 (Electronic) Linking ISSN: 14346621 NLM ISO Abbreviation: Clin Chem Lab Med Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/metabolism , Multiple Myeloma*/genetics , Multiple Myeloma*/diagnosis, Humans ; Glycosylation ; Proteomics/methods ; Tandem Mass Spectrometry ; Glycoproteins/metabolism ; Chromatography, Liquid ; Myeloma Proteins/metabolism ; Myeloma Proteins/analysis

المؤلفون: Fang W; Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, People's Republic of China., Girard N; Institut Curie, Paris, France., Cilento V; Cancer Research And Biostatistics (CRAB), Seattle, Washington., Goren E; Cancer Research And Biostatistics (CRAB), Seattle, Washington., Dibaba D; Cancer Research And Biostatistics (CRAB), Seattle, Washington., Ruffini E; University of Torino, Torino, Italy. Electronic address: enrico.ruffini@unito.it., Ahmad U; Thoracic Surgery in the Heart, Vascular & Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates., Appel S; Sheba Medical Center, Ramat Gan, Israel., Bille A; Guy's Hospital, London, United Kingdom., Boubia S; University Hospital Ibn Rochd, Casablanca, Morocco., Brambilla C; Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom., Cangir AK; Ankara University Faculty of Medicine, Ankara, Turkey., Detterbeck F; Yale University School of Medicine, New Haven, Connecticut., Falkson C; Queen's University at Kingston, Ontario, Canada., Filosso PL; Baggiovara Civil Hospital, University of Modena, Modena, Italy., Giaccone G; Meyer Cancer Center, Weill-Cornell Medicine, New York, New York., Guerrera F; University of Torino, Torino, Italy., Huang J; Memorial Sloan Kettering Cancer Center, New York, New York., Infante M; University and Hospital Trust, Verona, Italy., Kim DK; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lucchi M; Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Marino M; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Marom EM; Department of Diagnostic Imaging, Chaim Sheba Medical Center, Tel-Aviv University, Ramat Gan, Israel., Nicholson AG; Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom., Okumura M; National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan., Rami-Porta R; Hospital Universitari Mutua Terrassa, Terrassa, Spain, and Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain., Rimner A; Memorial Sloan Kettering Cancer Center, New York, New York., Simone CB 2nd; Memorial Sloan Kettering Cancer Center, New York, New York., Asamura H; Keio University, Tokyo, Japan.

مؤلفون مشاركون: Members of the Staging and Prognostic Factors Committee, Members of the Advisory Boards and Participating Institutions of the Thymic Domain

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Jan; Vol. 19 (1), pp. 52-70. Date of Electronic Publication: 2023 Sep 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/pathology , Thymoma*/pathology , Thymus Neoplasms*/pathology , Neoplasms, Glandular and Epithelial*/pathology , Neuroendocrine Tumors*/pathology, Humans ; Neoplasm Staging ; Myeloma Proteins ; Prognosis

SCR Disease Name: Thymic epithelial tumor

المؤلفون: Ruffini E; University of Torino, Torino, Italy. Electronic address: enrico.ruffini@unito.it., Huang J; Memorial Sloan Kettering Cancer Center, New York, New York., Cilento V; Cancer Research And Biostatistics (CRAB), Seattle, Washington., Goren E; Cancer Research And Biostatistics (CRAB), Seattle, Washington., Detterbeck F; Yale University School of Medicine, New Haven, Connecticut., Ahmad U; Thoracic Surgery in the Heart, Vascular, and Thoracic Institute at Cleveland Clinic, Abu Dhabi, United Arab Emirates., Appel S; Sheba Medical Center, Ramat Gan, Israel., Bille A; Guy's Hospital, London, United Kingdom., Boubia S; University Hospital Ibn Rochd, Casablanca, Morocco., Brambilla C; Royal Brompton and Harefield National Health Service (NHS) Hospitals, London, United Kingdom; Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom., Cangir AK; Ankara University Faculty of Medicine, Ankara, Turkey., Falkson C; Queen's University in Kingston, Ontario, Canada., Fang W; Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, People's Republic of China., Filosso PL; Baggiovara Civil Hospital, University of Modena, Italy., Giaccone G; Meyer Cancer Center, Weill-Cornell Medicine, New York, New York., Girard N; Institut Curie, Thorax Institute Curie Montsouris, Paris, France; Paris Saclay University, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Versailles, France., Guerrera F; University of Torino, Torino, Italy., Infante M; University and Hospital Trust, Verona, Italy., Kim DK; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lucchi M; Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Marino M; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy., Marom EM; Department of Diagnostic Imaging, Chaim Sheba Medical Center, Tel-Aviv University, Ramat Gan, Israel., Nicholson AG; Royal Brompton and Harefield National Health Service (NHS) Hospitals, London, United Kingdom; Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom., Okumura M; National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan., Rami-Porta R; Hospital Universitari Mutua Terrassa, Terrassa, Spain; Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain., Rimner A; Memorial Sloan Kettering Cancer Center, New York, New York., Simone CB 2nd; Memorial Sloan Kettering Cancer Center, New York, New York., Asamura H; Keio University, Tokyo, Japan.

مؤلفون مشاركون: Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards, and Participating Institutions

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Dec; Vol. 18 (12), pp. 1655-1671. Date of Electronic Publication: 2023 Sep 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/pathology , Thymus Neoplasms*/pathology , Thymoma*/pathology , Neuroendocrine Tumors*/pathology , Neoplasms, Glandular and Epithelial*/pathology, Humans ; Neoplasm Staging ; Prognosis ; Myeloma Proteins

SCR Disease Name: Thymic epithelial tumor

المؤلفون: Heaney JLJ; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Faustini S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Evans L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Rapson A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Collman E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Emery A; Department for Health, University of Bath, Bath, UK., Campbell JP; Department for Health, University of Bath, Bath, UK., Moore S; Royal United Hospitals Bath NHS Foundation Trust, Bath, UK., Goodall M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Afzal Z; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Chapple IL; Periodontal Research Group, School of Dentistry, Institute of Clinical Sciences, University of Birmingham, and Birmingham Community Health Trust, Birmingham, UK., Pratt G; University Hospitals Birmingham NHS Trust, Birmingham, UK., Drayson MT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

المصدر: European journal of haematology [Eur J Haematol] 2022 Jun; Vol. 108 (6), pp. 493-502. Date of Electronic Publication: 2022 Feb 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma* , Myeloma Proteins*, Humans ; Immunoglobulin A ; Immunoglobulin G ; Immunoglobulin Light Chains ; Immunoglobulins ; Saliva/metabolism

المؤلفون: Fatica EM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States., Martinez M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States., Ladwig PM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States., Murray JD; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States., Kohlhagen MC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States., Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, United States., Kourelis T; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States; Division of Hematology, Mayo Clinic, Rochester, MN, United States., Lust JA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States; Division of Hematology, Mayo Clinic, Rochester, MN, United States., Snyder MR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States., Dispenzieri A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States; Division of Hematology, Mayo Clinic, Rochester, MN, United States., Murray DL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States., Willrich MAV; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States. Electronic address: Willrich.MariaAlice@mayo.edu.

المصدر: Clinical biochemistry [Clin Biochem] 2021 Nov; Vol. 97, pp. 67-73. Date of Electronic Publication: 2021 Aug 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0133660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2933 (Electronic) Linking ISSN: 00099120 NLM ISO Abbreviation: Clin Biochem Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*blood , Immunoelectrophoresis/*methods , Myeloma Proteins/*analysis , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/*methods, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/chemistry ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulin G/chemistry ; Male ; Middle Aged ; Multiple Myeloma/blood ; Myeloma Proteins/chemistry ; Protein Multimerization ; Spectrometry, Mass, Electrospray Ionization

المؤلفون: Cao F; Department of Clinical Laboratory, the Affiliated Hospital of Qingdao University, Qingdao, China., Zhang R; Department of Clinical Laboratory, the Affiliated Hospital of Qingdao University, Qingdao, China., Xu L; Department of Clinical Laboratory, the Affiliated Hospital of Qingdao University, Qingdao, China., Liu M; Department of Clinical Laboratory, the Affiliated Hospital of Qingdao University, Qingdao, China., Yuan Y; Department of Clinical Laboratory, the Affiliated Hospital of Qingdao University, Qingdao, China yuanyuan51307@163.com.

المصدر: Annals of clinical and laboratory science [Ann Clin Lab Sci] 2021 May; Vol. 51 (3), pp. 400-407.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Institute for Clinical Science Country of Publication: United States NLM ID: 0410247 Publication Model: Print Cited Medium: Internet ISSN: 1550-8080 (Electronic) Linking ISSN: 00917370 NLM ISO Abbreviation: Ann Clin Lab Sci Subsets: MEDLINE

مواضيع طبية MeSH: Electrophoresis, Capillary/*methods , Immunoglobulin Light Chains/*blood , Immunoglobulin kappa-Chains/*blood , Immunoglobulin lambda-Chains/*blood , Multiple Myeloma/*diagnosis , Myeloma Proteins/*analysis , Paraproteinemias/*diagnosis, Blood Proteins/analysis ; Blood Proteins/immunology ; Diagnosis, Differential ; Humans ; Immunoglobulin Light Chains/immunology ; Immunoglobulin kappa-Chains/immunology ; Immunoglobulin lambda-Chains/immunology ; Multiple Myeloma/blood ; Multiple Myeloma/immunology ; Myeloma Proteins/immunology ; Paraproteinemias/blood ; Paraproteinemias/immunology ; ROC Curve ; Retrospective Studies

المؤلفون: Fujimura K; Department of Nursing, Yasuda Women's University, 6-13-1 Yasuhigashi Asaminami ward, Hiroshima City, 731-0153, Japan. k-fujimu@yasuda-u.ac.jp.; Hiroshima Atomic Bomb Causality Council, Hiroshima City, Japan. k-fujimu@yasuda-u.ac.jp., Sugiyama A; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan., Akita T; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan., Ohisa M; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan., Nagashima S; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan., Katayama K; Department of Nursing, Yasuda Women's University, 6-13-1 Yasuhigashi Asaminami ward, Hiroshima City, 731-0153, Japan.; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan., Maeda R; Hiroshima Atomic Bomb Causality Council, Hiroshima City, Japan., Tanaka J; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Japan.

المصدر: International journal of hematology [Int J Hematol] 2021 Apr; Vol. 113 (4), pp. 576-585. Date of Electronic Publication: 2021 Jan 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Atomic Bomb Survivors*/statistics & numerical data , Myeloma Proteins*, Monoclonal Gammopathy of Undetermined Significance/*blood , Monoclonal Gammopathy of Undetermined Significance/*epidemiology , Multiple Myeloma/*blood , Multiple Myeloma/*epidemiology, Adolescent ; Adult ; Aged ; Biomarkers, Tumor ; Child ; Female ; Follow-Up Studies ; Humans ; Immunoglobulin A/blood ; Immunoglobulin G/blood ; Immunoglobulin M ; Incidence ; Japan/epidemiology ; Kaplan-Meier Estimate ; Male ; Mass Screening ; Middle Aged ; Monoclonal Gammopathy of Undetermined Significance/diagnosis ; Monoclonal Gammopathy of Undetermined Significance/etiology ; Multiple Myeloma/diagnosis ; Multiple Myeloma/etiology ; Prevalence ; Proportional Hazards Models ; Risk Factors ; Young Adult

المؤلفون: Chen S; Department of Immunology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan., Kiguchi T; Department of Hematology, Chugoku Central Hospital, Fukuyama, Japan., Nagata Y; Division of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Tamai Y; Division of Hematology, Shonan Kamakura General Hospital, Kamakura, Japan., Ikeda T; Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan., Kajiya R; Department of Immunology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan., Ono T; Division of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Sugiyama D; Department of Immunology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan., Nishikawa H; Department of Immunology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan., Akatsuka Y; Department of Immunology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan. yakatsuk@med.nagoya-u.ac.jp.

المصدر: International journal of hematology [Int J Hematol] 2021 Apr; Vol. 113 (4), pp. 473-479. Date of Electronic Publication: 2021 Jan 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor*/blood , Immunoassay*/methods , Myeloma Proteins*, Antibodies, Monoclonal, Humanized/*pharmacokinetics , Antineoplastic Agents, Immunological/*pharmacokinetics , Multiple Myeloma/*blood , Multiple Myeloma/*diagnosis, Antibodies, Monoclonal, Humanized/therapeutic use ; Antineoplastic Agents, Immunological/therapeutic use ; Humans ; Multiple Myeloma/drug therapy ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/pharmacokinetics ; Recombinant Proteins/therapeutic use ; Signaling Lymphocytic Activation Molecule Family/administration & dosage ; Signaling Lymphocytic Activation Molecule Family/therapeutic use

المؤلفون: Saldanha A; Hospital das Clinicas, Faculdade de Medicina - Universidade de São Paulo (HCFMUSP), São Paulo, Brazil., Veiga ME; Hospital das Clinicas, Faculdade de Medicina - Universidade de São Paulo (HCFMUSP), São Paulo, Brazil., Okazaki E; Hospital das Clinicas, Faculdade de Medicina - Universidade de São Paulo (HCFMUSP), São Paulo, Brazil., Rothschild C; Hospital das Clinicas, Faculdade de Medicina - Universidade de São Paulo (HCFMUSP), São Paulo, Brazil., Martinez G; Hospital das Clinicas, Faculdade de Medicina - Universidade de São Paulo (HCFMUSP), São Paulo, Brazil., Rocha V; Hospital das Clinicas, Faculdade de Medicina - Universidade de São Paulo (HCFMUSP), São Paulo, Brazil., Orsi FA; Hospital das Clinicas, Faculdade de Medicina - Universidade de São Paulo (HCFMUSP), São Paulo, Brazil. ferorsi@unicamp.br.; Hematology and Hemotherapy, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 155. Cerqueira César, São Paulo, 13083-887, 05403-000, Brazil. ferorsi@unicamp.br.; Department of Pathology, School of Medical Sciences of the University of Campinas, Campinas, Brazil. ferorsi@unicamp.br., Villaca P; Hospital das Clinicas, Faculdade de Medicina - Universidade de São Paulo (HCFMUSP), São Paulo, Brazil.

المصدر: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2023 May; Vol. 55 (4), pp. 770-774. Date of Electronic Publication: 2023 Mar 31.

نوع المنشور: Case Reports; Letter

بيانات الدورية: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-742X (Electronic) Linking ISSN: 09295305 NLM ISO Abbreviation: J Thromb Thrombolysis Subsets: MEDLINE

مواضيع طبية MeSH: Monoclonal Gammopathy of Undetermined Significance*/complications , Monoclonal Gammopathy of Undetermined Significance*/drug therapy , Multiple Myeloma*/complications , Multiple Myeloma*/drug therapy , Paraproteinemias*/complications , Paraproteinemias*/drug therapy , von Willebrand Diseases*/complications , von Willebrand Diseases*/drug therapy, Humans ; Bortezomib/therapeutic use ; Myeloma Proteins